medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2013, Number S1

<< Back Next >>

Acta Ortop Mex 2013; 27 (S1)

Tratamiento antibiótico oral

Language: Spanish
References: 61
Page: 154-159
PDF size: 151.71 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Lora-Tamayo J, Murillo O, Iribarren JA, et al: A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention. Clin Infect Dis. 2012; 56(2): 182-194.

  2. Silva M, Tharani R, Schmalzried TP: Results of direct exchange or debridement of the infected total knee arthroplasty. Clin Orthop Relat Res. 2002; (404): 125-131.

  3. Achermann Y, Eigenmann K, Ledergerber B, et al: Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case-control study. Infection. 2013; 41(2): 431-437.

  4. Sia IG, Berbari EF, Karchmer AW: Prosthetic joint infections. Infect Dis Clin North Am. 2005; 19(4): 885-914.

  5. Berbari EF, Osmon DR, Duffy MC, et al: Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes. Clin Infect Dis. 2006; 42(2): 216-223.

  6. Fehring TK, Odum SM, Berend KR, et al: Failure of irrigation and debridement for early postoperative periprosthetic infection. Clin Orthop Relat Res. 2012; 471(1): 250-257.

  7. Baldoni D, Haschke M, Rajacic Z, Zimmerli W, Trampuz A: Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection. Antimicrob Agents Chemother. 2009; 53(3): 1142-1148.

  8. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A: The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999; 37(6): 1771-1776.

  9. Garrigos C, Murillo O, Euba G, et al: Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2010; 54(12): 5251-5256.

  10. Monzon M, Oteiza C, Leiva J, Lamata M, Amorena B: Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics. Diagn Microbiol Infect Dis. 2002; 44(4): 319-324.

  11. Saleh-Mghir A, Muller-Serieys C, Dinh A, Massias L, Cremieux AC: Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2011; 55(10): 4589-4593.

  12. Zimmerli W, Frei R, Widmer AF, Rajacic Z: Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother. 1994; 33(5): 959-967.

  13. Barberan J, Aguilar L, Carroquino G, et al: Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am J Med. 2006; 119(11): 993 e997-910.

  14. Byren I, Bejon P, Atkins BL, et al: One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother. 2009; 63(6): 1264-1271.

  15. Cobo J, Miguel LG, Euba G, et al: Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy. Clin Microbiol Infect. 2011; 17(11): 1632-1637.

  16. El Helou OC, Berbari EF, Lahr BD, et al: Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis. 2010; 29(8): 961-967.

  17. Giulieri SG, Graber P, Ochsner PE, Zimmerli W: Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection. 2004; 32(4): 222-228.

  18. Laffer RR, Graber P, Ochsner PE, Zimmerli W: Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect. 2006; 12(5): 433-439.

  19. Senneville E, Joulie D, Legout L, et al: Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus. Clin Infect Dis. 2011; 53(4): 334-340.

  20. Soriano A, Garcia S, Bori G, et al: Treatment of acute post-surgical infection of joint arthroplasty. Clin Microbio lInfect. 2006; 12(9): 930-933.

  21. Soriano A, Garcia S, Ortega M, et al: Treatment of acute infection of total or partial hip arthroplasty with debridement and oral chemotherapy. MedClin (Barc). 2003; 121(3): 81-85.

  22. Vílchez F, Martínez-Pastor JC, García-Ramiro S, et al: Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement. Clin Microbiol Infect. 2011; 17(3): 439-444.

  23. Anderl JN, Zahller J, Roe F, Stewart PS: Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother. 2003; 47(4): 1251-1256.

  24. Nijland HM, Ruslami R, Suroto AJ, et al: Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis. Clin Infect Dis. 2007; 45(8): 1001-1007.

  25. Zeller V, Dzeing-Ella A, Kitzis MD, Ziza JM, Mamoudy P, Desplaces N: Continuous clindamycin infusion, an innovative approach to treating bone and joint infections. Antimicrob Agents Chemother. 2010; 54(1): 88-92.

  26. Gandelman K, Zhu T, Fahmi OA, et al: Unexpected effect of rifampin on the pharmacokinetics of linezolid: in silico and in vitro approaches to explain its mechanism. J Clin Pharmacol. 2011; 51(2): 229-236.

  27. Tornero E, Garcia-Oltra E, Garcia-Ramiro S, et al: Prosthetic joint infections due to Staphylococcus aureus and coagulase-negative staphylococci. Int J Artif Organs. 2012; 35(10): 884-892.

  28. Bradbury T, Fehring TK, Taunton M, et al: The fate of acute methicillin-resistant Staphylococcus aureus periprosthetic knee infections treated by open debridement and retention of components. J Arthroplasty. 2009; 24(6 Suppl): 101-104.

  29. Ferry T, Uckay I, Vaudaux P, et al: Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection. Eur J Clin Microbiol Infect Dis. 2010; 29(2): 171-180.

  30. Salgado CD, Dash S, Cantey JR, Marculescu CE: Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res. 2007; 461: 48-53.

  31. Bassetti M, Vitale F, Melica G, et al: Linezolid in the treatment of Gram-positive prosthetic joint infections. J Antimicrob Chemother. 2005; 55(3): 387-390.

  32. Gomez J, Canovas E, Banos V, et al: Linezolid plus rifampin as a salvage therapy in prosthetic joint infections treated without removing the implant. Antimicrob Agents Chemother. 2011; 55(9): 4308-4310.

  33. Rao N, Hamilton CW: Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series. Diagn Microbiol Infect Dis. 2007; 59(2): 173-179.

  34. Rao N, Ziran BH, Hall RA, Santa ER: Successful treatment of chronic bone and joint infections with oral linezolid. Clin Orthop Relat Res. 2004; (427): 67-71.

  35. Razonable RR, Osmon DR, Steckelberg JM: Linezolid therapy for orthopedic infections. Mayo Clin Proc. 2004; 79(9): 1137-1144.

  36. Soriano A, Gomez J, Gomez L, et al: Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections. Eur J Clin Microbiol Infect Dis. 2007; 26(5): 353-356.

  37. Pea F, Furlanut M, Cojutti P, et al: Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis. Antimicrob Agents Chemother. 2010; 54(11): 4605-4610.

  38. Peel TN, Buising KL, Dowsey MM, et al: Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy. Antimicrob Agents Chemother. 2012; 57(1): 350-355.

  39. Stein A, Bataille JF, Drancourt M, et al: Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother. 1998; 42(12): 3086-3091.

  40. Wu WS, Chen CC, Chuang YC, et al: Efficacy of combination oral antimicrobial agents against biofilm-embedded methicillin-resistant Staphylococcus aureus. J Microbiol Immunol Infect. 2013; 46(2): 89-95.

  41. Meehan AM, Osmon DR, Duffy MC, Hanssen AD, Keating MR: Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. Clin Infect Dis. 2003; 36(7): 845-849.

  42. Odum SM, Fehring TK, Lombardi AV, et al: Irrigation and debridement for periprosthetic infections: does the organism matter? J Arthroplasty. 2011; 26(6 Suppl): 114-118.

  43. El Helou OC, Berbari EF, Marculescu CE, et al: Outcome of enterococcal prosthetic joint infection: is combination systemic therapy superior to monotherapy? Clin Infect Dis. 2008; 47(7): 903-909.

  44. Holmberg A, Morgelin M, Rasmussen M: Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms. J Antimicrob Chemother. 2012; 67(2): 433-439.

  45. Aboltins CA, Dowsey MM, Buising KL, et al: Gram-negative prosthetic joint infection treated with debridement, prosthesis retention and antibiotic regimens including a fluoroquinolone. Clin Microbio lInfect. 2011; 17(6): 862-867.

  46. Martinez-Pastor JC, Munoz-Mahamud E, Vilchez F, et al: Outcome of acute prosthetic joint infections due to Gram-negative bacilli treated with open debridement and retention of the prosthesis. Antimicrob Agents Chemother. 2009; 53(11): 4772-4777.

  47. San Juan R, Garcia-Reyne A, Caba P, et al: Safety and efficacy of moxifloxacin monotherapy for treatment of orthopedic implant-related staphylococcal infections. Antimicrob Agents Chemother. 2010; 54(12): 5161-5166.

  48. Daver NG, Shelburne SA, Atmar RL, et al: Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis. J Infect. 2007; 54(6): 539-544.

  49. Euba G, Murillo O, Fernandez-Sabe N, et al: Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis. Antimicrob Agents Chemother. 2009; 53(6): 2672-2676.

  50. Karamanis EM, Matthaiou DK, Moraitis LI, Falagas ME: Fluoroquinolones versus beta-lactam based regimens for the treatment of osteomyelitis: a meta-analysis of randomized controlled trials. Spine (Phila Pa 1976). 2008; 33(10): E297-304.

  51. Osmon DR, Berbari EF, Berendt AR, et al: Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013; 56(1): e1-e25.

  52. Zimmerli W, Trampuz A, Ochsner PE: Prosthetic-joint infections. N Engl J Med. 2004; 351(16): 1645-1654.

  53. Edmiston CE Jr, Goheen MP, Seabrook GR, et al: Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices. Am J Surg. 2006; 192(3): 344-354.

  54. Bernard L, Legout L, Zurcher-Pfund L, et al: Six weeks of antibiotic treatment is sufficient following surgery for septic arthroplasty. J Infect. 2010; 61(2): 125-132.

  55. Bejon P, Byren I, Atkins BL, et al: Serial measurement of the C-reactive protein is a poor predictor of treatment outcome in prosthetic joint infection. J Antimicrob Chemother. 2011; 66(7): 1590-1593.

  56. Bengtson S, Knutson K: The infected knee arthroplasty. A 6-year follow-up of 357 cases. Acta Orthop Scand. 1991; 62(4): 301-311.

  57. Koyonos L, Zmistowski B, Della Valle CJ, Parvizi J: Infection control rate of irrigation and debridement for periprosthetic joint infection. Clin Orthop Relat Res. 2011; 469(11): 3043-3048.

  58. Lentino JR: Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis. 2003; 36(9): 1157-1161.

  59. Marculescu CE, Berbari EF, Hanssen AD, et al: Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis. 2006; 42(4): 471-478.

  60. Rao N, Crossett LS, Sinha RK, Le Frock JL: Long-term suppression of infection in total joint arthroplasty. Clin Orthop Relat Res. 2003(414): 55-60.

  61. Segreti J, Nelson JA, Trenholme GM: Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis. 1998; 27(4): 711-713.




2020     |     www.medigraphic.com